Clinical Trials Browser

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05711667 2026-02-24

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Phase 3 Recruiting

105 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06652633 2026-02-05

Hesperia

Phase 3 Recruiting

546 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07186192 2026-01-28

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

Phase 3 Recruiting

190 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04448184 2026-01-08

PATH

Phase 3 Recruiting

662 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06449586 2025-12-15

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

Phase 3 Active not recruiting

250 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04620369 2025-12-03

Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy

Phase 3 Completed

106 enrolled 11 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT03136445 2025-10-28

TREATT

Phase 3 Completed

616 enrolled 34 charts

Other hematologic neoplasm

Hemorrhage, Hematologic Neoplasms

NCT04829539 2025-10-20

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Phase 3 Recruiting

400 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04260698 2025-07-02

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Phase 3 Completed

36 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06401356 2025-06-22

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Phase 3 Recruiting

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06108739 2025-06-03

ATG Plus Low-dose PT-Cy for GVHD Prevention

Phase 3 Terminated

66 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

Clinical Trials

MK-3475-587

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Hesperia

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

PATH

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy

TREATT

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

ATG Plus Low-dose PT-Cy for GVHD Prevention

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy